MiroBio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $414M

  • Investors
  • 1

MiroBio General Information

Description

Developer of novel therapeutics technology designed to bring significant benefits to patients suffering from a range of auto-immune diseases. The company's therapeutics activate natural mechanisms to regain control of overactive immune responses triggering these diseases and leverage natural signaling mechanisms to restore immune system balance and control, enabling clinicians to treat autoimmune diseases.

Contact Information

Website
www.mirobio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Winchester House, Heatley Road
  • Oxford Science Park
  • Oxford OX4 4GE
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Winchester House, Heatley Road
  • Oxford Science Park
  • Oxford OX4 4GE
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MiroBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 20-Sep-2022 $414M Completed Generating Revenue
3. Early Stage VC (Series B) 29-Jun-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 07-Oct-2019 $33.5M $33.5M Completed Generating Revenue
1. University Spin-Out 08-Oct-2018 Completed Startup
To view MiroBio’s complete valuation and funding history, request access »

MiroBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view MiroBio’s complete cap table history, request access »

MiroBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapeutics technology designed to bring significant benefits to patients suffering from a range of
Biotechnology
Oxford, United Kingdom
30 As of 2025

Cheyney, PA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MiroBio Competitors (43)

One of MiroBio’s 43 competitors is Navrogen, a Venture Capital-Backed company based in Cheyney, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Navrogen Venture Capital-Backed Cheyney, PA
Mestag Therapeutics Venture Capital-Backed Cambridge, United Kingdom
Macomics Venture Capital-Backed Edinburgh, United Kingdom
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 43 competitors. Get the full list »

MiroBio Patents

MiroBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026053130-A1 Anti-btla antibodies and uses of the same Pending 03-Sep-2024
AU-2023251091-A1 Engineered cd200r antibodies and uses thereof Pending 06-Apr-2022
AU-2023251091-A2 Engineered cd200r antibodies and uses thereof Pending 06-Apr-2022
EP-4504786-A1 Engineered cd200r antibodies and uses thereof Pending 06-Apr-2022
US-20230416361-A1 Engineered cd200r antibodies and uses thereof Pending 06-Apr-2022 C07K16/2803
To view MiroBio’s complete patent history, request access »

MiroBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MiroBio Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent Life Sciences Venture Capital Minority
Medicxi Ventures (UK) Venture Capital Minority
Monograph Capital Venture Capital Minority
OrbiMed Growth/Expansion Minority
Oxford Science Enterprises Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

MiroBio FAQs

  • When was MiroBio founded?

    MiroBio was founded in 2018.

  • Where is MiroBio headquartered?

    MiroBio is headquartered in Oxford, United Kingdom.

  • What is the size of MiroBio?

    MiroBio has 30 total employees.

  • What industry is MiroBio in?

    MiroBio’s primary industry is Biotechnology.

  • Is MiroBio a private or public company?

    MiroBio is a Private company.

  • What is the current valuation of MiroBio?

    The current valuation of MiroBio is .

  • What is MiroBio’s current revenue?

    The current revenue for MiroBio is .

  • How much funding has MiroBio raised over time?

    MiroBio has raised $130M.

  • Who are MiroBio’s investors?

    Advent Life Sciences, Medicxi Ventures (UK), Monograph Capital, OrbiMed, and Oxford Science Enterprises are 5 of 7 investors who have invested in MiroBio.

  • Who are MiroBio’s competitors?

    Navrogen, Mestag Therapeutics, Macomics, NovaBiotics, and Inovio Pharmaceuticals are some of the 43 competitors of MiroBio.

  • When was MiroBio acquired?

    MiroBio was acquired on 20-Sep-2022.

  • Who acquired MiroBio?

    MiroBio was acquired by Gilead.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process